A report dated 9 October 2025 describes an employee-benefit captive offering developed by Advisory Services Network and Nordisk Aktuarservice. The proposed approach models HR-related risks, including stress, absenteeism and sick leave, to help organisations assess their total cost of risk before considering mitigation and financing choices.

The report includes participant statements and discussion of Bayer evaluating the approach. It does not provide an independently assessed dataset demonstrating employer savings or improved health outcomes. Its description establishes the intended method and purpose, rather than proof that the offering will deliver equivalent results across organisations.

Define the decision before choosing the model For a multinational benefits team, the useful question is what a measurement exercise would change. Management should identify the decisions under review and explain which information is needed to support them. Financing an exposure and reducing the underlying harm are related objectives, but success on one does not establish success on the other.

A model should make its definitions and boundaries visible. The organisation needs to understand which costs are included, which are omitted and how information from different functions is combined. Without that explanation, a single headline figure may conceal differences in recording practices or scope.

Connect functions without overstating precision HR, finance and captive risk teams can bring different information to the same problem. Their cooperation should clarify the relationship between insured expenditure and wider workforce costs. The purpose is not to assume that a premium reduction represents an equivalent improvement in employee wellbeing or a reduction in total organisational loss.

Data quality and uncertainty deserve their own discussion. A useful board paper should distinguish observed information from assumptions and explain where the model is sensitive to those assumptions. Personal employee information requires a defined purpose and appropriate handling; additional data should not be collected simply because a modelling tool can use it.

Test incentives and evidence This editor recommends that independent directors ask how the proposed measurement supports a specific decision and how results would be evaluated. Provider remuneration and interests in the subsequent financing arrangement should be understandable. Management should also explain what evidence would justify continuing, modifying or stopping the exercise.

The offering provides a concrete example of bringing HR risks into captive analysis. Its editorial value lies in those questions about scope and accountability. Until independently evaluated results are available, claims about savings or improved outcomes should remain attributed proposals rather than established benefits.